Fig. 4From: Reduction in resource use with the misoprostol vaginal insert vs the dinoprostone vaginal insert for labour induction: a model-based analysis from a United Kingdom healthcare perspectiveProportion of women experiencing treatment-related AEs with the DVI vs the MVIBack to article page